Archangels

Archangels, a prominent business angel syndicate founded in 1992 and headquartered in Edinburgh, has been a key player in early stage investing in Scotland for over two decades. With more than 60 investor members, Archangels coordinates investments exceeding £10 million annually in early stage Scottish companies, focusing on technology, software, and life sciences sectors. Committed to giving back, supporting young Scottish companies, generating attractive investment returns, and fostering a fun environment, Archangels leverages its executive team's diverse expertise to aid in the creation and growth of startups, ultimately aiming to maximize investor returns.

Niki McKenzie

Joint Managing Director

David Ovens

Joint Managing Director

77 past transactions

CSignum

Series A in 2025
CSignum specializes in wireless communications solutions, digitization of subsea assets, and actionable insights for ocean industries.

Neuranics

Seed Round in 2025
Neuranics is a company focused on developing advanced magnetic sensors integrated with semiconductor technology for applications in health, fitness, and the metaverse. Their proprietary technology is designed to detect minute magnetic impulses produced by the body's organs, utilizing scalable spintronics sensors. This innovative approach aims to address the limitations of current health monitoring devices and enhance human-machine interfaces. By leveraging magnetic sensing, Neuranics seeks to improve the interaction with the central, peripheral, and autonomic nervous systems, as well as muscles, thereby offering significant advancements for healthcare companies in creating next-generation wearable and implantable devices.

Cytomos

Venture Round in 2024
Cytomos Limited is a biotechnology company based in Edinburgh, United Kingdom, that specializes in developing advanced cell sorting devices for laboratory research and clinical diagnostics. Founded in 2011, the company utilizes its patented Dielectric Spectroscopy (CDS) technology to enable label-free cell analysis, providing detailed insights at single-cell resolution. This technology supports various applications in biopharma and cell therapy by facilitating automated, quantitative assessments of samples and enhancing phenotypic drug discovery. Cytomos’ system is designed to scale across all upstream production stages, leveraging machine learning algorithms to analyze extensive data from individual cells, thus improving the efficiency of cell-based diagnostics and enabling researchers to optimize therapeutic dosing.

Administrate

Venture Round in 2024
Administrate Limited is a cloud-based training management solution provider based in Edinburgh, United Kingdom, with an additional office in Bozeman, Montana. Established in 2007, the company offers a suite of tools designed to support training companies, internal training departments, and educational institutions. Its primary offerings include CORE, a training management system; a Learning Management System for eLearning; and WEB, which facilitates automatic course listings and online bookings. These solutions enable users to define employee learning plans, manage course logistics, and track progress over time. Administrate's platform is designed to enhance operational efficiency and support data-driven decision-making, making it suitable for a variety of training environments, including executive education and vocational training, both in the United Kingdom and internationally.

iGii

Venture Round in 2024
iGii specializes in the development of innovative manufacturing processes for producing high-performance, pure 3D graphene foam. This foam can be applied directly onto various surfaces at room temperature and within seconds, making it a highly efficient solution for manufacturers. iGii's customizable and scalable foam enhances the electrochemically active surface area, significantly improving the performance of supercapacitors with fast charging capabilities and extended battery life. By addressing common issues related to cost, variability, and stability in the production process, iGii provides a unique offering that supports advancements in energy storage technology.

1inhaler

Seed Round in 2023
1inhaler operates as a developer of drug delivery device.

Bio-Images Drug Delivery

Venture Round in 2023
Bio-Images Drug Delivery Ltd, based in Glasgow, United Kingdom, specializes in drug formulation and delivery systems. The company offers a comprehensive range of services tailored to meet individual client needs, including troubleshooting, formulation development, and both in vitro and in vivo testing. Bio-Images is known for its patented time release technology, OralogiK, which provides precise control over drug release timing and location, allowing for the oral delivery of single, multi-dose, or combination drugs within a timeframe of one to twelve hours after ingestion. This technology supports various dosing strategies, such as nighttime administration and multi-phased delivery, which enhance therapeutic efficacy. Additionally, the company employs gamma scintigraphy to analyze the in vivo behavior of formulations, offering insights into disintegration timing, gastric emptying, and gastrointestinal transit. Bio-Images also features a clinical division that manages all aspects of clinical study processes, from protocol development and regulatory submissions to the production of compliant clinical study reports.

Cytomos

Series A in 2023
Cytomos Limited is a biotechnology company based in Edinburgh, United Kingdom, that specializes in developing advanced cell sorting devices for laboratory research and clinical diagnostics. Founded in 2011, the company utilizes its patented Dielectric Spectroscopy (CDS) technology to enable label-free cell analysis, providing detailed insights at single-cell resolution. This technology supports various applications in biopharma and cell therapy by facilitating automated, quantitative assessments of samples and enhancing phenotypic drug discovery. Cytomos’ system is designed to scale across all upstream production stages, leveraging machine learning algorithms to analyze extensive data from individual cells, thus improving the efficiency of cell-based diagnostics and enabling researchers to optimize therapeutic dosing.

Administrate

Venture Round in 2023
Administrate Limited is a cloud-based training management solution provider based in Edinburgh, United Kingdom, with an additional office in Bozeman, Montana. Established in 2007, the company offers a suite of tools designed to support training companies, internal training departments, and educational institutions. Its primary offerings include CORE, a training management system; a Learning Management System for eLearning; and WEB, which facilitates automatic course listings and online bookings. These solutions enable users to define employee learning plans, manage course logistics, and track progress over time. Administrate's platform is designed to enhance operational efficiency and support data-driven decision-making, making it suitable for a variety of training environments, including executive education and vocational training, both in the United Kingdom and internationally.

PaperTrl

Seed Round in 2023
PaperTrl is a cloud-based procure-to-pay software platform designed to enhance the accounts payable (AP) processes for organizations that require robust vendor management. Founded in response to the needs of Tidewater, Inc., a federal contractor in Baltimore, Maryland, PaperTrl emerged as a solution to streamline vendor sourcing, selection, purchasing, and payment. The platform facilitates the entire AP process, enabling users to issue purchase orders, track receipts, process invoices, and make payments efficiently, all from a user-friendly interface. Recognizing the demand for an affordable and easily implementable AP automation solution, the founders aimed to serve a market that was previously underserved. With experienced leadership from industry veterans, PaperTrl has quickly gained traction among users and vendors, transforming AP functions and driving significant operational efficiencies.

Bioliberty

Seed Round in 2023
Bioliberty is a medtech start-up focused on creating innovative rehabilitation solutions for individuals with degenerative and traumatic conditions. The company develops robotic gloves that leverage artificial intelligence to facilitate muscle recovery. By utilizing assistive robotics and rehabilitative devices, Bioliberty aims to support patients suffering from various ailments, including stroke, motor neuron disease, multiple sclerosis, rheumatoid arthritis, and osteoarthritis. These devices are designed to assist users in overcoming hand weakness, enabling them to perform daily tasks more effectively and enhance their hand strength, ultimately promoting greater independence and comfort in their own homes.

Hearing Diagnostics

Seed Round in 2022
Hearing Diagnostics Limited is a health-tech startup based in Edinburgh, United Kingdom, focused on developing innovative hearing screening and diagnostic products. Incorporated in 2017, the company offers tools such as Audimetroid, which utilizes head motion sensors to facilitate localization-based hearing screenings. These products are designed for use by healthcare professionals, including nurses, audiologists, and otolaryngologists, allowing for objective assessments of hearing loss. The technology aims to provide effective and cost-efficient hearing screenings, employing a spatial paradigm where patients listen to sounds through headphones while utilizing inertia measurement sensors. This approach enables accessible and efficient hearing tests in community settings, addressing the challenges of unmanaged hearing loss and promoting earlier intervention for affected individuals.

PhysioMedics

Venture Round in 2022
PhysioMedics is a healthcare technology company focused on enhancing the management of musculoskeletal disorders through its online software solutions. The company has developed a self-assessment platform that offers data analytics, personalized self-help advice, and information to connect back pain sufferers with appropriate treatment pathways. This approach enables patients to take an active role in their healthcare, leading to improved outcomes. Additionally, PhysioMedics' platform assists organizations in reducing costs associated with absenteeism and enhances overall efficiency in managing musculoskeletal conditions.

Cytomos

Seed Round in 2022
Cytomos Limited is a biotechnology company based in Edinburgh, United Kingdom, that specializes in developing advanced cell sorting devices for laboratory research and clinical diagnostics. Founded in 2011, the company utilizes its patented Dielectric Spectroscopy (CDS) technology to enable label-free cell analysis, providing detailed insights at single-cell resolution. This technology supports various applications in biopharma and cell therapy by facilitating automated, quantitative assessments of samples and enhancing phenotypic drug discovery. Cytomos’ system is designed to scale across all upstream production stages, leveraging machine learning algorithms to analyze extensive data from individual cells, thus improving the efficiency of cell-based diagnostics and enabling researchers to optimize therapeutic dosing.

Earth Blox

Seed Round in 2022
Earth Blox is a developer of earth observation software that facilitates the analysis of satellite imagery for a diverse range of users, including businesses, NGOs, universities, and research institutions focused on sustainability and climate change. The platform offers access to over 900 Earth Engine datasets and features no-code workflows, allowing data analysts to efficiently create and run analyses. Earth Blox provides valuable insights into the environmental impacts and dependencies of portfolios containing millions of assets and facilities, helping organizations navigate complex supply chains. Additionally, it delivers tailored pre-built solutions aligned with global sustainability standards and methodologies, enabling users to address risks and identify opportunities in their operations. By unlocking custom nature and climate insights, Earth Blox supports organizations in their sustainability initiatives and climate mitigation efforts.

BioCaptiva

Seed Round in 2022
BioCaptiva is a developer of innovative liquid biopsy technology that focuses on the early diagnosis and monitoring of difficult-to-detect cancers. The company's platform is designed to capture circulating free DNA from patients' blood in larger quantities, addressing the limitations commonly associated with current liquid biopsy testing methods. This advancement enables healthcare professionals to explore new approaches for detecting and monitoring various cancers, ultimately aiming to improve patient outcomes through more effective diagnostics.

Speech Graphics

Series A in 2022
Speech Graphics Ltd, founded in 2010 and based in Edinburgh, United Kingdom, specializes in procedural facial animation solutions for the entertainment industry. The company offers SGX, a software that transforms audio files and transcripts into high-quality facial animations without the need for motion capture. Its technology has been utilized in various productions, including AAA video games and music videos, and serves applications in communication and training. The firm emerged from the University of Edinburgh's School of Informatics and has collaborated with notable clients such as Warner Brothers and Def Jam Recordings. Speech Graphics has garnered several awards for its innovative technology, including the John Logie Baird Award, and has received development grants from organizations like Scottish Enterprise.

BioCaptiva

Seed Round in 2021
BioCaptiva is a developer of innovative liquid biopsy technology that focuses on the early diagnosis and monitoring of difficult-to-detect cancers. The company's platform is designed to capture circulating free DNA from patients' blood in larger quantities, addressing the limitations commonly associated with current liquid biopsy testing methods. This advancement enables healthcare professionals to explore new approaches for detecting and monitoring various cancers, ultimately aiming to improve patient outcomes through more effective diagnostics.

Bio-Images Drug Delivery

Venture Round in 2020
Bio-Images Drug Delivery Ltd, based in Glasgow, United Kingdom, specializes in drug formulation and delivery systems. The company offers a comprehensive range of services tailored to meet individual client needs, including troubleshooting, formulation development, and both in vitro and in vivo testing. Bio-Images is known for its patented time release technology, OralogiK, which provides precise control over drug release timing and location, allowing for the oral delivery of single, multi-dose, or combination drugs within a timeframe of one to twelve hours after ingestion. This technology supports various dosing strategies, such as nighttime administration and multi-phased delivery, which enhance therapeutic efficacy. Additionally, the company employs gamma scintigraphy to analyze the in vivo behavior of formulations, offering insights into disintegration timing, gastric emptying, and gastrointestinal transit. Bio-Images also features a clinical division that manages all aspects of clinical study processes, from protocol development and regulatory submissions to the production of compliant clinical study reports.

iGii

Seed Round in 2020
iGii specializes in the development of innovative manufacturing processes for producing high-performance, pure 3D graphene foam. This foam can be applied directly onto various surfaces at room temperature and within seconds, making it a highly efficient solution for manufacturers. iGii's customizable and scalable foam enhances the electrochemically active surface area, significantly improving the performance of supercapacitors with fast charging capabilities and extended battery life. By addressing common issues related to cost, variability, and stability in the production process, iGii provides a unique offering that supports advancements in energy storage technology.

Speech Graphics

Venture Round in 2020
Speech Graphics Ltd, founded in 2010 and based in Edinburgh, United Kingdom, specializes in procedural facial animation solutions for the entertainment industry. The company offers SGX, a software that transforms audio files and transcripts into high-quality facial animations without the need for motion capture. Its technology has been utilized in various productions, including AAA video games and music videos, and serves applications in communication and training. The firm emerged from the University of Edinburgh's School of Informatics and has collaborated with notable clients such as Warner Brothers and Def Jam Recordings. Speech Graphics has garnered several awards for its innovative technology, including the John Logie Baird Award, and has received development grants from organizations like Scottish Enterprise.

Optoscribe

Venture Round in 2020
Optoscribe Limited is a company based in Livingston, United Kingdom, specializing in the development and manufacturing of 3D light waveguides for the optical telecommunications sector. Founded in 2010, Optoscribe provides innovative solutions, including ultra-low crosstalk multicore fiber fanout products that facilitate connections between single-mode and multi-core fibers. Its unique 3D glass-based photonic integrated circuit platform is tailored for custom transceiver fiber coupling, addressing the challenges posed by various optical transceiver architectures. This platform enhances the compactness and robustness of optical interconnects, significantly improving data transfer capabilities across networks while minimizing costs. Optoscribe's products support advanced fiber technologies, including Single Mode, Multimode, and Multicore Fibers, and are designed for seamless integration into diverse communications applications. The company's manufacturing processes allow for scalability and are engineered to meet the rigorous demands of the telecommunications market.

Calcivis

Venture Round in 2019
Calcivis, a privately held company based in Edinburgh, Scotland, was founded in 2012 to address a significant need in the field of dentistry. The company specializes in a dental imaging platform that offers visual evidence of tooth demineralization, enabling dentists to identify active decay at an early stage. This innovative technology, co-invented with the University of Dundee and LUX Innovate, allows for the differentiation between active and non-active lesions on tooth surfaces, promoting preventive dentistry. By facilitating early intervention, Calcivis aims to help prevent the progression of cavities that would otherwise require invasive treatments. The company operates using a virtual development model, collaborating with various contract research and manufacturing organizations primarily located in Scotland.

MGB Biopharma

Venture Round in 2019
MGB Biopharma Limited is a biopharmaceutical company based in Bellshill, United Kingdom, specializing in the development of a new class of anti-infective medicines derived from minor groove binder compounds. Established in 2009, the company focuses on creating small molecules with specific antibacterial properties to combat both multi-resistant and susceptible Gram-positive bacteria. One of its key products, MGB-BP-3, is an antibacterial agent designed for the oral treatment of Clostridium difficile-associated disease. MGB Biopharma aims to address the challenges of antibiotic resistance by employing a novel mode of action that targets bacteria lacking inherent resistance mechanisms, offering a promising approach to treating bacterial infections effectively.

QueryClick

Venture Round in 2019
QueryClick is a digital marketing agency that specializes in enhancing the return on investment for brands through its innovative technology and data-driven insights. It addresses the challenges faced by brands lacking effective attribution models and those concerned about ad viewability. Utilizing machine learning and historical data, QueryClick's unique attribution forecasting technology simulates billions of potential outcomes, allowing its consultants to recommend real-time adjustments to clients' marketing strategies. This capability enables clients to optimize their multi-channel marketing efforts, including paid and organic search, programmatic display, social campaigns, and conversion rate optimization. QueryClick's clientele includes notable brands such as New Look, EE, BT Group, and Tesco, reflecting its ability to deliver measurable improvements in channel performance through its proprietary optimization techniques.

Speech Graphics

Venture Round in 2019
Speech Graphics Ltd, founded in 2010 and based in Edinburgh, United Kingdom, specializes in procedural facial animation solutions for the entertainment industry. The company offers SGX, a software that transforms audio files and transcripts into high-quality facial animations without the need for motion capture. Its technology has been utilized in various productions, including AAA video games and music videos, and serves applications in communication and training. The firm emerged from the University of Edinburgh's School of Informatics and has collaborated with notable clients such as Warner Brothers and Def Jam Recordings. Speech Graphics has garnered several awards for its innovative technology, including the John Logie Baird Award, and has received development grants from organizations like Scottish Enterprise.

Administrate

Series A in 2019
Administrate Limited is a cloud-based training management solution provider based in Edinburgh, United Kingdom, with an additional office in Bozeman, Montana. Established in 2007, the company offers a suite of tools designed to support training companies, internal training departments, and educational institutions. Its primary offerings include CORE, a training management system; a Learning Management System for eLearning; and WEB, which facilitates automatic course listings and online bookings. These solutions enable users to define employee learning plans, manage course logistics, and track progress over time. Administrate's platform is designed to enhance operational efficiency and support data-driven decision-making, making it suitable for a variety of training environments, including executive education and vocational training, both in the United Kingdom and internationally.

Speech Graphics

Venture Round in 2018
Speech Graphics Ltd, founded in 2010 and based in Edinburgh, United Kingdom, specializes in procedural facial animation solutions for the entertainment industry. The company offers SGX, a software that transforms audio files and transcripts into high-quality facial animations without the need for motion capture. Its technology has been utilized in various productions, including AAA video games and music videos, and serves applications in communication and training. The firm emerged from the University of Edinburgh's School of Informatics and has collaborated with notable clients such as Warner Brothers and Def Jam Recordings. Speech Graphics has garnered several awards for its innovative technology, including the John Logie Baird Award, and has received development grants from organizations like Scottish Enterprise.

Optoscribe

Series C in 2018
Optoscribe Limited is a company based in Livingston, United Kingdom, specializing in the development and manufacturing of 3D light waveguides for the optical telecommunications sector. Founded in 2010, Optoscribe provides innovative solutions, including ultra-low crosstalk multicore fiber fanout products that facilitate connections between single-mode and multi-core fibers. Its unique 3D glass-based photonic integrated circuit platform is tailored for custom transceiver fiber coupling, addressing the challenges posed by various optical transceiver architectures. This platform enhances the compactness and robustness of optical interconnects, significantly improving data transfer capabilities across networks while minimizing costs. Optoscribe's products support advanced fiber technologies, including Single Mode, Multimode, and Multicore Fibers, and are designed for seamless integration into diverse communications applications. The company's manufacturing processes allow for scalability and are engineered to meet the rigorous demands of the telecommunications market.

MGB Biopharma

Venture Round in 2018
MGB Biopharma Limited is a biopharmaceutical company based in Bellshill, United Kingdom, specializing in the development of a new class of anti-infective medicines derived from minor groove binder compounds. Established in 2009, the company focuses on creating small molecules with specific antibacterial properties to combat both multi-resistant and susceptible Gram-positive bacteria. One of its key products, MGB-BP-3, is an antibacterial agent designed for the oral treatment of Clostridium difficile-associated disease. MGB Biopharma aims to address the challenges of antibiotic resistance by employing a novel mode of action that targets bacteria lacking inherent resistance mechanisms, offering a promising approach to treating bacterial infections effectively.

Calcivis

Venture Round in 2018
Calcivis, a privately held company based in Edinburgh, Scotland, was founded in 2012 to address a significant need in the field of dentistry. The company specializes in a dental imaging platform that offers visual evidence of tooth demineralization, enabling dentists to identify active decay at an early stage. This innovative technology, co-invented with the University of Dundee and LUX Innovate, allows for the differentiation between active and non-active lesions on tooth surfaces, promoting preventive dentistry. By facilitating early intervention, Calcivis aims to help prevent the progression of cavities that would otherwise require invasive treatments. The company operates using a virtual development model, collaborating with various contract research and manufacturing organizations primarily located in Scotland.

Canopy Biosciences

Series A in 2018
Canopy Biosciences is a biotechnology company specializing in research tools for gene editing, molecular biology, and personalized medicine. Founded in 2016 and headquartered in St. Louis, Missouri, the company offers a range of products and services designed to enhance scientific discovery in biomedical research. Its gene editing technology, known as TUNR, facilitates targeted modifications in the genome by inserting polyA tracks into specific coding regions, which reduces mRNA levels and subsequently suppresses protein expression. This innovative approach supports researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, advancing the fields of genetic engineering and gene expression analysis. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

Blackford Analysis

Angel Round in 2018
Blackford Analysis Ltd. specializes in software solutions that enhance the comparison of medical images, thereby saving clinicians time and improving productivity in healthcare settings. Founded in 2010 and based in Edinburgh, the company offers products such as the Blackford Workflow Server, which integrates into hospital IT frameworks, and the Blackford Smart Localizer, designed for seamless comparison of imaging studies within existing systems. These tools enable users to conduct comparisons with a single click, typically resulting in time savings of 10% to 20%. Blackford’s technology employs advanced algorithms and multi-core processing to facilitate rapid registration of scans from various sources. The company partners with multiple imaging system providers and has expanded its reach by collaborating with organizations outside diagnostic imaging to enhance their offerings. Blackford Analysis has experienced significant growth, with sales offices in both the UK and the United States, and continues to develop bespoke image processing solutions to meet diverse healthcare needs.

Bio-Images Drug Delivery

Venture Round in 2018
Bio-Images Drug Delivery Ltd, based in Glasgow, United Kingdom, specializes in drug formulation and delivery systems. The company offers a comprehensive range of services tailored to meet individual client needs, including troubleshooting, formulation development, and both in vitro and in vivo testing. Bio-Images is known for its patented time release technology, OralogiK, which provides precise control over drug release timing and location, allowing for the oral delivery of single, multi-dose, or combination drugs within a timeframe of one to twelve hours after ingestion. This technology supports various dosing strategies, such as nighttime administration and multi-phased delivery, which enhance therapeutic efficacy. Additionally, the company employs gamma scintigraphy to analyze the in vivo behavior of formulations, offering insights into disintegration timing, gastric emptying, and gastrointestinal transit. Bio-Images also features a clinical division that manages all aspects of clinical study processes, from protocol development and regulatory submissions to the production of compliant clinical study reports.

PhysioWizard

Venture Round in 2017
PHYSIOWIZARD® is online software used by occupational, healthcare and insurance providers to offer personalised triage, risk assessment and the most appropriate treatment pathway for employees and patients suffering back pain.

Calcivis

Venture Round in 2017
Calcivis, a privately held company based in Edinburgh, Scotland, was founded in 2012 to address a significant need in the field of dentistry. The company specializes in a dental imaging platform that offers visual evidence of tooth demineralization, enabling dentists to identify active decay at an early stage. This innovative technology, co-invented with the University of Dundee and LUX Innovate, allows for the differentiation between active and non-active lesions on tooth surfaces, promoting preventive dentistry. By facilitating early intervention, Calcivis aims to help prevent the progression of cavities that would otherwise require invasive treatments. The company operates using a virtual development model, collaborating with various contract research and manufacturing organizations primarily located in Scotland.

Optoscribe

Series B in 2017
Optoscribe Limited is a company based in Livingston, United Kingdom, specializing in the development and manufacturing of 3D light waveguides for the optical telecommunications sector. Founded in 2010, Optoscribe provides innovative solutions, including ultra-low crosstalk multicore fiber fanout products that facilitate connections between single-mode and multi-core fibers. Its unique 3D glass-based photonic integrated circuit platform is tailored for custom transceiver fiber coupling, addressing the challenges posed by various optical transceiver architectures. This platform enhances the compactness and robustness of optical interconnects, significantly improving data transfer capabilities across networks while minimizing costs. Optoscribe's products support advanced fiber technologies, including Single Mode, Multimode, and Multicore Fibers, and are designed for seamless integration into diverse communications applications. The company's manufacturing processes allow for scalability and are engineered to meet the rigorous demands of the telecommunications market.

MGB Biopharma

Venture Round in 2017
MGB Biopharma Limited is a biopharmaceutical company based in Bellshill, United Kingdom, specializing in the development of a new class of anti-infective medicines derived from minor groove binder compounds. Established in 2009, the company focuses on creating small molecules with specific antibacterial properties to combat both multi-resistant and susceptible Gram-positive bacteria. One of its key products, MGB-BP-3, is an antibacterial agent designed for the oral treatment of Clostridium difficile-associated disease. MGB Biopharma aims to address the challenges of antibiotic resistance by employing a novel mode of action that targets bacteria lacking inherent resistance mechanisms, offering a promising approach to treating bacterial infections effectively.

Reactec

Angel Round in 2017
Reactec specializes in developing innovative solutions to address arm and hand vibration syndrome, focusing on improving workplace safety and worker welfare. The Reactec Analytics Platform automates the monitoring of worker exposure to vibration, eliminating the need for traditional paperwork. This platform enables employers to access real-time data on individual and company-wide exposure trends with ease, allowing them to identify workers who have surpassed health and safety thresholds. Additionally, it provides insights into tool rotation, performance, and utilization, thereby enhancing management capabilities related to worker efficiency and overall health. By delivering reliable information online, Reactec aims to support organizations in fostering safer work environments.

Inquisitive Systems

Series A in 2017
Inquisitive Systems Ltd., founded in 2008 and based in Edinburgh, United Kingdom, specializes in developing data protection software aimed at safeguarding intellectual property from security breaches. The company’s flagship product, foxDNATM, originated from a postgraduate project by co-founder Dr. Jamie Graves and has evolved into a comprehensive solution that examines relevant data, provides alerts, and monitors forensic user activity. After initiating commercial trading in 2010, Inquisitive Systems has positioned itself as an ambitious contender in the information security software market, leveraging its strong academic roots as a spin-out from Edinburgh Napier University. The company aims to establish itself as a global leader in this space.

ZoneFox

Series A in 2017
ZoneFox Limited is a security software provider based in Edinburgh, United Kingdom, that specializes in protecting business-critical assets, data, and intellectual property for various industries, including finance, healthcare, high-tech, biotech, and legal. Founded in 2008, the company offers solutions for data monitoring, analytics, and endpoint security, focusing on insider threat detection, behavior analytics, network monitoring, instant alerting, and compliance reporting. Its enterprise security platform delivers cloud-based threat analytics, enabling organizations to gain rapid insights into user behavior and data flow while maintaining user privacy. ZoneFox’s technology helps clients effectively address insider threats, thereby reducing the risks of data theft, leakage, and misuse. The company operates as a subsidiary of Fortinet, Inc., following its acquisition in 2018.

Administrate

Angel Round in 2016
Administrate Limited is a cloud-based training management solution provider based in Edinburgh, United Kingdom, with an additional office in Bozeman, Montana. Established in 2007, the company offers a suite of tools designed to support training companies, internal training departments, and educational institutions. Its primary offerings include CORE, a training management system; a Learning Management System for eLearning; and WEB, which facilitates automatic course listings and online bookings. These solutions enable users to define employee learning plans, manage course logistics, and track progress over time. Administrate's platform is designed to enhance operational efficiency and support data-driven decision-making, making it suitable for a variety of training environments, including executive education and vocational training, both in the United Kingdom and internationally.

Ateeda

Venture Round in 2016
Ateeda Limited, based in Edinburgh, United Kingdom, specializes in the design and manufacture of testing modules and electronic design automation tools for the semiconductor industry. The company provides analog test modules tailored for high-precision testing of audio and instrumentation integrated circuits, serving sectors such as HD audio, precision medical, industrial, and automotive markets. Its offerings include built-in self-test capabilities for linear circuits and digital testing for analog circuits, aimed at enhancing the efficiency and quality of electronic chip manufacturing. Established in 2005 and formerly known as York Place (No. 359) Limited, Ateeda focuses on helping microchip enterprises reduce production costs while meeting the stringent testing specifications demanded by leading consumer brands in the mobile and wearable technology sectors.

Arrayjet

Venture Round in 2016
Arrayjet Limited, established in 2000 and based in Roslin, United Kingdom, specializes in the development and manufacturing of microarray printers, accessories, and consumables for the global research, drug development, and diagnostic sectors. The company is known for its patented inkjet technology that prints biological samples onto solid substrates, creating microarrays used for screening tools. Arrayjet's offerings include the JetMosphere, an environmental control system that ensures consistent printing conditions, along with a range of microarray consumables and outsourced services such as assay development, optimization, and custom microarray services. Since its commercialization in 2006, Arrayjet has built a strong brand presence and reputation for high-throughput inkjet printing systems and reliable customer service, catering to a diverse customer base across 27 countries. In addition to its instrument business, Arrayjet has expanded its contract service capabilities, launching specialized services for assay development, project management, and training.

LUX Assure

Venture Round in 2016
LUX Assure Limited specializes in developing and delivering advanced chemical monitoring technologies for the oil and gas industry, both offshore and onshore. The company offers innovative solutions such as CoMic, which helps determine the optimal dosage of corrosion inhibitors, and a variety of testing kits that facilitate onsite or offshore colorimetric analysis. Their products are designed to monitor chemical concentrations, including scale, corrosion, and hydrate inhibitors in water and hydrocarbons. Established in 2001 and based in Edinburgh, United Kingdom, LUX Assure has gained recognition for its robust and user-friendly technologies, earning awards for innovation within the industry. The company serves clients in the UK and internationally, providing essential tools for effectively managing chemical usage in extraction processes.

Optoscribe

Series A in 2016
Optoscribe Limited is a company based in Livingston, United Kingdom, specializing in the development and manufacturing of 3D light waveguides for the optical telecommunications sector. Founded in 2010, Optoscribe provides innovative solutions, including ultra-low crosstalk multicore fiber fanout products that facilitate connections between single-mode and multi-core fibers. Its unique 3D glass-based photonic integrated circuit platform is tailored for custom transceiver fiber coupling, addressing the challenges posed by various optical transceiver architectures. This platform enhances the compactness and robustness of optical interconnects, significantly improving data transfer capabilities across networks while minimizing costs. Optoscribe's products support advanced fiber technologies, including Single Mode, Multimode, and Multicore Fibers, and are designed for seamless integration into diverse communications applications. The company's manufacturing processes allow for scalability and are engineered to meet the rigorous demands of the telecommunications market.

Administrate

Seed Round in 2015
Administrate Limited is a cloud-based training management solution provider based in Edinburgh, United Kingdom, with an additional office in Bozeman, Montana. Established in 2007, the company offers a suite of tools designed to support training companies, internal training departments, and educational institutions. Its primary offerings include CORE, a training management system; a Learning Management System for eLearning; and WEB, which facilitates automatic course listings and online bookings. These solutions enable users to define employee learning plans, manage course logistics, and track progress over time. Administrate's platform is designed to enhance operational efficiency and support data-driven decision-making, making it suitable for a variety of training environments, including executive education and vocational training, both in the United Kingdom and internationally.

Bloxx

Venture Round in 2015
Bloxx, Ltd. specializes in developing and supporting email and web filtering technologies designed to protect public and private enterprises from internet threats. The company offers a range of solutions, including a web content filter that provides real-time content analysis, a secure web gateway that safeguards users from inappropriate content and security threats, and an email filter that delivers multi-level spam protection, malware defense, and comprehensive reporting features. Utilizing its patented Tru-View technology, Bloxx performs real-time content categorization to enhance online security. The company's products are available through various deployment options, including hardware, virtual, and cloud-based solutions, allowing integration with existing infrastructures. Bloxx serves multiple sectors, including education, healthcare, government, and corporate clients. Founded in 1999 and headquartered in Livingston, United Kingdom, Bloxx also has offices in the United States and Europe.

PowerPhotonic

Venture Round in 2015
PowerPhotonic Limited specializes in the design and manufacturing of precision micro-optics for various applications, including laser projection systems, optical telecommunications, and industrial materials processing. The company offers a diverse range of products, such as high-powered diode laser optics, microlens arrays, beam shapers, and refractive diffusers. Additionally, PowerPhotonic provides design and prototyping services to cater to specific customer needs. Founded in 2004, the company is headquartered in Dalgety Bay, United Kingdom, with operational reach extending to North America and Southeast Asia. Their micro-optical fabrication technology enables clients to access a comprehensive selection of standard and custom optical solutions, enhancing the performance of laser systems across multiple sectors.

MGB Biopharma

Series B in 2014
MGB Biopharma Limited is a biopharmaceutical company based in Bellshill, United Kingdom, specializing in the development of a new class of anti-infective medicines derived from minor groove binder compounds. Established in 2009, the company focuses on creating small molecules with specific antibacterial properties to combat both multi-resistant and susceptible Gram-positive bacteria. One of its key products, MGB-BP-3, is an antibacterial agent designed for the oral treatment of Clostridium difficile-associated disease. MGB Biopharma aims to address the challenges of antibiotic resistance by employing a novel mode of action that targets bacteria lacking inherent resistance mechanisms, offering a promising approach to treating bacterial infections effectively.

Cytomos

Venture Round in 2014
Cytomos Limited is a biotechnology company based in Edinburgh, United Kingdom, that specializes in developing advanced cell sorting devices for laboratory research and clinical diagnostics. Founded in 2011, the company utilizes its patented Dielectric Spectroscopy (CDS) technology to enable label-free cell analysis, providing detailed insights at single-cell resolution. This technology supports various applications in biopharma and cell therapy by facilitating automated, quantitative assessments of samples and enhancing phenotypic drug discovery. Cytomos’ system is designed to scale across all upstream production stages, leveraging machine learning algorithms to analyze extensive data from individual cells, thus improving the efficiency of cell-based diagnostics and enabling researchers to optimize therapeutic dosing.

Fios Genomics

Venture Round in 2013
Fios Genomics Ltd. is a bioinformatics company based in Edinburgh, UK, specializing in data analysis services for the pharmaceutical, biotech, and academic sectors worldwide. Founded in 2008 as a spinout from the University of Edinburgh, Fios Genomics offers a comprehensive suite of services, including microarray analysis, next-generation sequencing, proteomics, and metabolomics. Its capabilities extend to biomarker identification, gene expression analysis, and experimental design, allowing clients to leverage genomic, transcriptomic, and proteomic data through tailored workflows. The company serves a diverse clientele, including major pharmaceutical firms, clinical centers, and research institutions across Europe, the United States, and Asia, supporting applications in pre-clinical and clinical development, drug repurposing, and stratified medicine.

Inquisitive Systems

Venture Round in 2013
Inquisitive Systems Ltd., founded in 2008 and based in Edinburgh, United Kingdom, specializes in developing data protection software aimed at safeguarding intellectual property from security breaches. The company’s flagship product, foxDNATM, originated from a postgraduate project by co-founder Dr. Jamie Graves and has evolved into a comprehensive solution that examines relevant data, provides alerts, and monitors forensic user activity. After initiating commercial trading in 2010, Inquisitive Systems has positioned itself as an ambitious contender in the information security software market, leveraging its strong academic roots as a spin-out from Edinburgh Napier University. The company aims to establish itself as a global leader in this space.

LUX Assure

Funding Round in 2013
LUX Assure Limited specializes in developing and delivering advanced chemical monitoring technologies for the oil and gas industry, both offshore and onshore. The company offers innovative solutions such as CoMic, which helps determine the optimal dosage of corrosion inhibitors, and a variety of testing kits that facilitate onsite or offshore colorimetric analysis. Their products are designed to monitor chemical concentrations, including scale, corrosion, and hydrate inhibitors in water and hydrocarbons. Established in 2001 and based in Edinburgh, United Kingdom, LUX Assure has gained recognition for its robust and user-friendly technologies, earning awards for innovation within the industry. The company serves clients in the UK and internationally, providing essential tools for effectively managing chemical usage in extraction processes.

Calcivis

Venture Round in 2012
Calcivis, a privately held company based in Edinburgh, Scotland, was founded in 2012 to address a significant need in the field of dentistry. The company specializes in a dental imaging platform that offers visual evidence of tooth demineralization, enabling dentists to identify active decay at an early stage. This innovative technology, co-invented with the University of Dundee and LUX Innovate, allows for the differentiation between active and non-active lesions on tooth surfaces, promoting preventive dentistry. By facilitating early intervention, Calcivis aims to help prevent the progression of cavities that would otherwise require invasive treatments. The company operates using a virtual development model, collaborating with various contract research and manufacturing organizations primarily located in Scotland.

Blackford Analysis

Angel Round in 2012
Blackford Analysis Ltd. specializes in software solutions that enhance the comparison of medical images, thereby saving clinicians time and improving productivity in healthcare settings. Founded in 2010 and based in Edinburgh, the company offers products such as the Blackford Workflow Server, which integrates into hospital IT frameworks, and the Blackford Smart Localizer, designed for seamless comparison of imaging studies within existing systems. These tools enable users to conduct comparisons with a single click, typically resulting in time savings of 10% to 20%. Blackford’s technology employs advanced algorithms and multi-core processing to facilitate rapid registration of scans from various sources. The company partners with multiple imaging system providers and has expanded its reach by collaborating with organizations outside diagnostic imaging to enhance their offerings. Blackford Analysis has experienced significant growth, with sales offices in both the UK and the United States, and continues to develop bespoke image processing solutions to meet diverse healthcare needs.

NCTech

Venture Round in 2012
NCTech Ltd, founded in 2010 and based in Edinburgh, United Kingdom, specializes in designing and manufacturing 360-degree reality imaging systems that enhance image documentation workflows. The company produces a range of advanced cameras, including the iSTAR and iris360 models, which are utilized for point-to-point measurements and colorizing point clouds. NCTech's software solutions, such as Immersive Studio and ColourCloud, facilitate the processing and export of captured data. Their products cater to various industries, including engineering, surveying, law enforcement, and immersive media, and are available through online platforms and a network of distributors and resellers across the Americas, Europe, Asia, and the Middle East. The iSTAR range, known for its high-resolution imaging capabilities, supports applications in autonomous driving, smart city initiatives, and virtual reality reconstructions, leveraging cloud-based processing, machine learning, and artificial intelligence to enhance data analysis and interpretation.

Flexitricity

Venture Round in 2012
Flexitricity is a pioneer in demand response solutions, having shaped demand-side flexibility since its inception in 2004. Operating as a subsidiary of Reserve Power Holdings, the company focuses on developing a greener and fairer energy system through its smart grid technology. Flexitricity aggregates demand response resources, offering services such as short-term operating reserves and frequency response. This approach allows clients to enhance asset reliability, decrease national carbon dioxide emissions, and contribute to energy security. Through its innovations, Flexitricity addresses the complexities of the energy market, positioning itself as a leader in promoting sustainable energy practices.

Touch Bionics

Venture Round in 2011
Touch Bionics Limited, located in Livingston, Scotland, specializes in the development and marketing of advanced upper-limb prosthetics aimed at patients with upper-limb deficiencies. The company's notable products include the i-LIMB Hand, a multi-articulating bionic hand designed to assist amputees, and self-contained powered Prosthetic Digits, which offer functionality for individuals with partial hand loss. Additionally, Touch Bionics provides ProDigits, a solution for patients missing fingers. Their offerings extend to highly realistic passive functional prostheses, which are designed to closely resemble the natural appearance of the wearer. Touch Bionics distributes its innovative products across various regions, including the United States, Europe, Asia, and parts of South America and Africa. Established in 2003, the company was previously known as Touch EMAS Limited and rebranded in 2005. As of 2016, Touch Bionics operates as a subsidiary of Ossur Hf.

Fios Genomics

Series B in 2011
Fios Genomics Ltd. is a bioinformatics company based in Edinburgh, UK, specializing in data analysis services for the pharmaceutical, biotech, and academic sectors worldwide. Founded in 2008 as a spinout from the University of Edinburgh, Fios Genomics offers a comprehensive suite of services, including microarray analysis, next-generation sequencing, proteomics, and metabolomics. Its capabilities extend to biomarker identification, gene expression analysis, and experimental design, allowing clients to leverage genomic, transcriptomic, and proteomic data through tailored workflows. The company serves a diverse clientele, including major pharmaceutical firms, clinical centers, and research institutions across Europe, the United States, and Asia, supporting applications in pre-clinical and clinical development, drug repurposing, and stratified medicine.

Ateeda

Venture Round in 2010
Ateeda Limited, based in Edinburgh, United Kingdom, specializes in the design and manufacture of testing modules and electronic design automation tools for the semiconductor industry. The company provides analog test modules tailored for high-precision testing of audio and instrumentation integrated circuits, serving sectors such as HD audio, precision medical, industrial, and automotive markets. Its offerings include built-in self-test capabilities for linear circuits and digital testing for analog circuits, aimed at enhancing the efficiency and quality of electronic chip manufacturing. Established in 2005 and formerly known as York Place (No. 359) Limited, Ateeda focuses on helping microchip enterprises reduce production costs while meeting the stringent testing specifications demanded by leading consumer brands in the mobile and wearable technology sectors.

MGB Biopharma

Series A in 2010
MGB Biopharma Limited is a biopharmaceutical company based in Bellshill, United Kingdom, specializing in the development of a new class of anti-infective medicines derived from minor groove binder compounds. Established in 2009, the company focuses on creating small molecules with specific antibacterial properties to combat both multi-resistant and susceptible Gram-positive bacteria. One of its key products, MGB-BP-3, is an antibacterial agent designed for the oral treatment of Clostridium difficile-associated disease. MGB Biopharma aims to address the challenges of antibiotic resistance by employing a novel mode of action that targets bacteria lacking inherent resistance mechanisms, offering a promising approach to treating bacterial infections effectively.

Touch Bionics

Debt Financing in 2010
Touch Bionics Limited, located in Livingston, Scotland, specializes in the development and marketing of advanced upper-limb prosthetics aimed at patients with upper-limb deficiencies. The company's notable products include the i-LIMB Hand, a multi-articulating bionic hand designed to assist amputees, and self-contained powered Prosthetic Digits, which offer functionality for individuals with partial hand loss. Additionally, Touch Bionics provides ProDigits, a solution for patients missing fingers. Their offerings extend to highly realistic passive functional prostheses, which are designed to closely resemble the natural appearance of the wearer. Touch Bionics distributes its innovative products across various regions, including the United States, Europe, Asia, and parts of South America and Africa. Established in 2003, the company was previously known as Touch EMAS Limited and rebranded in 2005. As of 2016, Touch Bionics operates as a subsidiary of Ossur Hf.

PowerPhotonic

Grant in 2009
PowerPhotonic Limited specializes in the design and manufacturing of precision micro-optics for various applications, including laser projection systems, optical telecommunications, and industrial materials processing. The company offers a diverse range of products, such as high-powered diode laser optics, microlens arrays, beam shapers, and refractive diffusers. Additionally, PowerPhotonic provides design and prototyping services to cater to specific customer needs. Founded in 2004, the company is headquartered in Dalgety Bay, United Kingdom, with operational reach extending to North America and Southeast Asia. Their micro-optical fabrication technology enables clients to access a comprehensive selection of standard and custom optical solutions, enhancing the performance of laser systems across multiple sectors.

Adventi

Venture Round in 2009
Adventi was formed in 2002 by Graham Bucknall, the aim of the business was to provide IT support to small businesses that did not have their own IT support function. The target in the first year was sign up 60 clients. In 2003, the company acquired the IT support division of CVG, this was the first acquisition and expanded the business resulting in the company having operational bases in Edinburgh and Glasgow. It doubled the client base and by now was employing circa 30 people. In 2005, Adventi acquired Scotsys creating a business with a turnover of £16M. Adventi, already an accredited Microsoft Partner moved into new territory with Scotsys, a company providing Apple products through two retail outlets and supplying over 80% of Apple Mac computers into schools in Scotland. Scotsys also had a training business In 2007, the business now known as The Adventi Group acquires Integral Arm, a managed services business with circa 400 clients. Today, Adventi is a full service IT business providing a range of IT products, services and solutions to a client base in excess of 600 and growing. Our partnerships with some of the world’s leading IT business, such as Microsoft, Cisco, Apple, Steljes and HP results in a innovatively unique set of propositions unmatched in the UK..

Ateeda

Venture Round in 2008
Ateeda Limited, based in Edinburgh, United Kingdom, specializes in the design and manufacture of testing modules and electronic design automation tools for the semiconductor industry. The company provides analog test modules tailored for high-precision testing of audio and instrumentation integrated circuits, serving sectors such as HD audio, precision medical, industrial, and automotive markets. Its offerings include built-in self-test capabilities for linear circuits and digital testing for analog circuits, aimed at enhancing the efficiency and quality of electronic chip manufacturing. Established in 2005 and formerly known as York Place (No. 359) Limited, Ateeda focuses on helping microchip enterprises reduce production costs while meeting the stringent testing specifications demanded by leading consumer brands in the mobile and wearable technology sectors.

CXR Biosciences

Venture Round in 2008
CXR Biosciences Limited specializes in preclinical services, focusing on investigative and mechanistic toxicology, as well as metabolic and pharmacokinetics/toxicokinetics. The company evaluates human hazard and risk, offering solutions for chemical design, candidate selection, and translational risk assessment. CXR generates critical data for PK/TK and metabolic profiling, assisting clients in addressing safety concerns related to drug and chemical candidates. Its technological capabilities include in vivo and in vitro analyses, analytical techniques, microarrays, and toxicogenomics, among others. CXR serves a diverse range of sectors, including pharmaceuticals, agrochemicals, biotechnology, and consumer products. Founded in 2000 and based in Dundee, United Kingdom, the company collaborates with over sixty customers, including pharmaceutical and chemical companies, research institutions, and universities, to enhance the drug development process and chemical safety assessments.

PowerPhotonic

Venture Round in 2008
PowerPhotonic Limited specializes in the design and manufacturing of precision micro-optics for various applications, including laser projection systems, optical telecommunications, and industrial materials processing. The company offers a diverse range of products, such as high-powered diode laser optics, microlens arrays, beam shapers, and refractive diffusers. Additionally, PowerPhotonic provides design and prototyping services to cater to specific customer needs. Founded in 2004, the company is headquartered in Dalgety Bay, United Kingdom, with operational reach extending to North America and Southeast Asia. Their micro-optical fabrication technology enables clients to access a comprehensive selection of standard and custom optical solutions, enhancing the performance of laser systems across multiple sectors.

Lab901

Venture Round in 2006
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.

Trig Avionics

Venture Round in 2006
Trig Avionics Limited is a UK-based company specializing in the design and manufacture of avionics products for general aviation. Founded in 2004 and headquartered in Edinburgh, Trig Avionics develops innovative and compact technologies, including Mode S transponders and altitude monitors, which cater to the needs of aircraft owners and operators. The company is committed to producing certified avionics equipment that complies with EASA and FAA regulations, ensuring that customers have access to reliable and affordable solutions. Trig Avionics not only supports highly skilled jobs in the UK but also exports its products to over 40 countries worldwide. Additionally, the company is actively involved in grassroots aviation, sponsoring the Trig Aerobatic Team to promote its brand within the flying community.

Adventi

Venture Round in 2005
Adventi was formed in 2002 by Graham Bucknall, the aim of the business was to provide IT support to small businesses that did not have their own IT support function. The target in the first year was sign up 60 clients. In 2003, the company acquired the IT support division of CVG, this was the first acquisition and expanded the business resulting in the company having operational bases in Edinburgh and Glasgow. It doubled the client base and by now was employing circa 30 people. In 2005, Adventi acquired Scotsys creating a business with a turnover of £16M. Adventi, already an accredited Microsoft Partner moved into new territory with Scotsys, a company providing Apple products through two retail outlets and supplying over 80% of Apple Mac computers into schools in Scotland. Scotsys also had a training business In 2007, the business now known as The Adventi Group acquires Integral Arm, a managed services business with circa 400 clients. Today, Adventi is a full service IT business providing a range of IT products, services and solutions to a client base in excess of 600 and growing. Our partnerships with some of the world’s leading IT business, such as Microsoft, Cisco, Apple, Steljes and HP results in a innovatively unique set of propositions unmatched in the UK..

Lab901

Venture Round in 2005
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.

Critiqom

Venture Round in 2005
Critiqom Limited is a UK-based provider of critical communication services, specializing in personalized business documents. Founded in 1995 and originally named Document Outsourcing Ltd., the company changed its name in 2015 and operates from multiple locations, including Bellshill, Warrington, Brentford, Leeds, Newcastle upon Tyne, Birmingham, and Cardiff. Critiqom offers a range of services, including data management, printing, mailing, and hybrid mail solutions, which encompass archiving, returns, and virtual mailroom capabilities. The company's Primepost service provides reliable day-definite postal delivery for both public and private sector clients. By focusing on cost-effective outsourcing solutions, Critiqom aims to help customers reduce mailing expenses and enhance delivery efficiency. As of December 2019, Critiqom Limited operates as a subsidiary of Opus Trust Communications.

Mpathy Medical

Venture Round in 2003
Mpathy Medical Devices Limited is a company specializing in the development and marketing of minimally invasive surgical devices aimed at restoring pelvic health in women. It offers innovative mesh products designed to treat conditions such as stress urinary incontinence and pelvic organ prolapse. These devices feature a physiologically compatible, ultra-lightweight mesh that promotes superior collagen growth, ensuring optimal safety and effective outcomes for patients. Mpathy Medical focuses on providing healthcare professionals with the tools necessary to improve women's health through advanced surgical solutions.

Lab901

Venture Round in 2002
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.

Arrayjet

Venture Round in 2001
Arrayjet Limited, established in 2000 and based in Roslin, United Kingdom, specializes in the development and manufacturing of microarray printers, accessories, and consumables for the global research, drug development, and diagnostic sectors. The company is known for its patented inkjet technology that prints biological samples onto solid substrates, creating microarrays used for screening tools. Arrayjet's offerings include the JetMosphere, an environmental control system that ensures consistent printing conditions, along with a range of microarray consumables and outsourced services such as assay development, optimization, and custom microarray services. Since its commercialization in 2006, Arrayjet has built a strong brand presence and reputation for high-throughput inkjet printing systems and reliable customer service, catering to a diverse customer base across 27 countries. In addition to its instrument business, Arrayjet has expanded its contract service capabilities, launching specialized services for assay development, project management, and training.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.